GENAZZANI, Alessandro
 Distribuzione geografica
Continente #
NA - Nord America 17.757
EU - Europa 7.182
AS - Asia 3.096
SA - Sud America 62
AF - Africa 38
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 3
Totale 28.152
Nazione #
US - Stati Uniti d'America 17.705
GB - Regno Unito 2.940
IT - Italia 1.206
SG - Singapore 1.105
CN - Cina 946
SE - Svezia 838
DE - Germania 559
UA - Ucraina 549
HK - Hong Kong 398
TR - Turchia 387
FI - Finlandia 281
RU - Federazione Russa 237
BG - Bulgaria 222
FR - Francia 70
ID - Indonesia 52
BR - Brasile 40
IE - Irlanda 40
IN - India 40
ES - Italia 36
NL - Olanda 34
LT - Lituania 32
CA - Canada 28
IR - Iran 28
PL - Polonia 21
BE - Belgio 20
JP - Giappone 19
MX - Messico 19
RO - Romania 19
EG - Egitto 18
PK - Pakistan 18
PH - Filippine 17
AU - Australia 12
KR - Corea 12
MY - Malesia 12
VN - Vietnam 12
PT - Portogallo 10
CZ - Repubblica Ceca 9
IL - Israele 9
PE - Perù 8
GR - Grecia 7
HU - Ungheria 7
CH - Svizzera 6
IQ - Iraq 6
CL - Cile 5
JO - Giordania 5
SA - Arabia Saudita 5
YE - Yemen 5
AT - Austria 4
EE - Estonia 4
MA - Marocco 4
MD - Moldavia 4
RS - Serbia 4
AL - Albania 3
AZ - Azerbaigian 3
BD - Bangladesh 3
EU - Europa 3
GH - Ghana 3
MK - Macedonia 3
NG - Nigeria 3
SI - Slovenia 3
TH - Thailandia 3
TZ - Tanzania 3
ZA - Sudafrica 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
BZ - Belize 2
CO - Colombia 2
DK - Danimarca 2
EC - Ecuador 2
KE - Kenya 2
KG - Kirghizistan 2
MO - Macao, regione amministrativa speciale della Cina 2
MT - Malta 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
UG - Uganda 2
UY - Uruguay 2
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
IS - Islanda 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
ME - Montenegro 1
PA - Panama 1
QA - Qatar 1
SM - San Marino 1
VE - Venezuela 1
Totale 28.152
Città #
Southend 2.535
Fairfield 2.494
Santa Clara 2.028
Woodbridge 1.618
Ashburn 1.272
Houston 1.261
Jacksonville 1.184
Chandler 1.040
Seattle 909
Wilmington 825
Ann Arbor 772
Cambridge 751
Singapore 732
Dearborn 678
Nyköping 534
Hong Kong 392
Modena 318
Beijing 288
Princeton 242
San Diego 235
Sofia 219
Eugene 193
Izmir 164
Helsinki 95
Moscow 91
London 79
Bremen 67
Redwood City 65
Des Moines 62
Shanghai 62
Milan 58
Bologna 50
Rome 43
Norwalk 42
Jakarta 39
Dublin 38
Falls Church 37
Boardman 33
Guangzhou 29
New York 29
Dongguan 23
Hefei 23
Kilburn 23
Philadelphia 23
Parma 22
Kunming 19
Chiswick 18
Hounslow 18
San Mateo 18
Brussels 16
Istanbul 16
Nanjing 16
Indiana 15
Brescia 14
Naples 14
Turin 14
Auburn Hills 13
Florence 13
Frankfurt am Main 13
Jinan 13
Verona 13
Dong Ket 12
Palermo 12
Paris 12
Amsterdam 11
Briona 11
Cagliari 11
Los Angeles 11
Saint Petersburg 11
Bari 8
Cairo 8
Lima 8
Mountain View 8
Acton 7
Berlin 7
Fuzhou 7
Nanchang 7
Pontedera 7
Pune 7
Quezon City 7
Ravenna 7
Tel Aviv 7
Athens 6
Karachi 6
Monmouth Junction 6
Prato 6
Prescot 6
Southwark 6
Sydney 6
Warsaw 6
Wuhan 6
Ardabil 5
Augusta 5
Bergamo 5
Borgosesia 5
Castelfranco Veneto 5
Chicago 5
Dallas 5
Forlì 5
Genoa 5
Totale 22.245
Nome #
Increased adrenal steroid secretion in response to CRF in women with hypothalamic amenorrhea 612
Effects of a Combination of Alpha Lipoic Acid and Myo-Inositol on Insulin Dynamics in Overweight/Obese Patients with PCOS. 288
Spontaneous endogenous pulsatile release of kisspeptin is temporally coupled with luteinizing hormone in healthy women 232
Inositol as putative integrative treatment for PCOS 231
Androgens Regulate T47D Cells Motility and Invasion through Actin Cytoskeleton Remodeling 206
Acetyl-L-Carnitine (ALC) administration positively affects reproductive axis in hypogonadotropic women with functional hypothalamic amenorrhea 201
Diagnostic and therapeutic approach to hypothalamic amenorrhea. 198
Modulatory role of D-chiro-inositol (DCI) on LH and insulin secretion in obese PCOS patients 197
Differential insulin response to myo-inositol administration in obese polycystic ovary syndrome patients 197
Myo-inositol modulates insulin and luteinizing hormone secretion in normal weight patients with polycystic ovary syndrome 197
Use of metformin in the treatment of polycystic ovary syndrome 196
Acute infusion of naloxone, an opioid receptor antagonist, does not modify serum leptin concentrations in amenorrheic and healthy women 195
Metformin administration is more effective when non-obese patients with polycystic ovary syndrome show both hyperandrogenism and hyperinsulinemia 194
Inositol and human reproduction. From cellular metabolism to clinical use 191
Modulatory effects of alpha-lipoic acid (ALA) administration on insulin sensitivity in obese PCOS patients 191
Validation of italian version of the Women's Health Questionnaire: Assessment of quality of life of women from the general population and those attending menopause centers 189
Effect of a 2-month treatment with Klamin®, a Klamath algae extract, on the general well-being, antioxidant profile and oxidative status of postmenopausal women 189
Myo-inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome 187
Estriol administration modulates luteinizing hormone secretion in women with functional hypothalamic amenorrhea 182
Advances in neurosteroids: Role in clinical practice 182
Effetto degli estratti di alga Klamath sul benessere e sui fenomeni di stress ossidativo nelle pazienti in menopausa 182
Allopregnanolone concentration in hippocampus of prepubertal rats and female rats throughout estrous cycle 178
Modulatory effects of l-carnitine plus l-acetyl-carnitine on neuroendocrine control of hypothalamic functions in functional hypothalamic amenorrhea (FHA) 177
Short-term estriol administration modulates hypothalamo-pituitary function in patients with functional hypothalamic amenorrhea (FHA) 176
FSH SECRETORY PATTERN AND DEGREE OF CONCORDANCE WITH LH IN AMENORRHEIC, FERTILE, AND POSTMENOPAUSAL WOMEN. 175
Analgesia and endocrine surgical stress: effect of two analgesia protocols on cortisol and prolactin levels during abdominal aortic aneurysm endovascular repair. 174
Hypothalamic amenorrhea: from diagnosis to therapeutical approach. 174
Dall'uso del solo DHEA alla sua associazione con la terapia ormonale sostitutiva 173
The role of color doppler imaging in the diagnosis of polycystic ovary syndrome 172
Progestins modulate the action of estrogen on gonadotropin-releasing hormone, luteinizing hormone and prolactin in the rat. 172
Effects of estetrol on migration and invasion inT47-D breast cancer cells through the actin cytoskeleton 171
Metformin administration restores allopregnanolone response to adrenocorticotropic hormone (ACTH) stimulation in overweight hyperinsulinemic patients with PCOS 170
Estimation of instantaneous secretory rates and intrinsic characteristics of luteinizing hormone secretion in women with Kallmann syndrome before and after estriol administration. 169
Hypothalamic-pituitary-gonadal axis in two men with aromatase deficiency: evidence that circulating estrogens are required at the hypothalamic level for the integrity of gonadotropin negative feedback 169
A comparative study of three ovulation induction protocols in polycystic ovarian disease patients in an in vitro fertilization/embryo transfer program. 168
Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause 168
Dydrogesterone exerts endothelial anti-inflammatory actions decreasing expression of leukocyte adhesion molecules 168
Actin Cytoskeleton Remodelling by Sex Steroids in Neurones 164
Neuroendocrine effects of different estradiol-progestin regimens in postmenopausal women 164
The duration of prolactin secretory bursts from the pituitary is independent from both prolactin and gonadal steroid plasma levels in women and in men 163
Effects of red clover extracts on breast cancer cell migration and invasion 162
Hypothalamic amenorrhea in a Camurati-Engelmann disease-a case report 162
Ovulation induction with myo-inositol alone and in combination with clomiphene citrate in polycystic ovarian syndrome patients with insulin resistance 162
Estrogen regulates endothelial migration via plasminogen activator inhibitor (PAI-1) 161
Color Doppler analysis in lean and obese women with polycystic ovary syndrome. 161
Effects of hormone replacement therapy on plasma viscosity and Doppler variations in postmenopausal non-smokers and heavy smokers 160
Might DHEA be Considered a Beneficial Replacement Therapy in the Elderly ? 160
Changes in Dopaminergic control of circulating melanocyte- stimulating hormone-related peptides at puberty. 157
Luteinizing hormone (LH) secretory burst duration is independent from LH, prolactin, or gonadal steroid plasma levels in amenorrheic women. 157
FREQUENCY OF PROLACTIN PULSATILE RELEASE IN NORMAL MEN AND IN AGONADAL PATIENTS IS NEITHER COUPLED TO LH-RELEASE NOR INFLUENCED BY ANDROGEN MODULATION 157
Color Doppler analysis in oligo and amenorrheic women with polycystic ovary syndrome 156
A long-term treatment with gonadotropin-releasing hormone agonist plus a low-dose oral contraceptive improves the recovery of the ovulatory function in patients with polycystic ovary syndrome. 156
Obesità e benessere: i rischi per la salute della donna obesa 155
Bollettino di Endocrinologia Ginecologica 155
Surgical technique of endometrioma excision impacts on the ovarian reserve. Single-port access laparoscopy versus multiport access laparoscopy: a case control study 155
Episodic secretion of activin A in pregnant women 154
Pivagabine decreases stress-related hormone secretion in women with hypothalamic amenorrhea 154
Ultrasonographic and color Doppler analysis in the treatment of polycystic ovary syndrome 154
Adrenal function under long-term raloxifene administration 153
EFFECT OF CORTICOTROPIN-RELEASING FACTOR-BINDING PROTEIN ON PROSTAGLANDIN RELEASE FROM CULTURED MATERNAL DECIDUA AND ON CONTRACTILE ACTIVITY OF HUMAN MYOMETRIUM IN-VITRO 152
Estetrol modulates endothelial nitric oxide synthesis in human endothelial cells 152
Different concentrations of interleukins in the peritoneal fluid of women with endometriosis: relationships with lymphocyte subsets 151
Naltrexone administration modulates the neuroendocrine control of luteinizing hormone secretion in hypothalamic amenorrhoea. 151
Allopregnanolone and dehydroepiandrosterone response to corticotropin-releasing factor in patients suffering from Alzheimer's disease and vascular dementia 151
Neuroendocrine correlates of premenstrual syndrome: changes in the pulsatile pattern of plasma LH. 150
Maternal plasma and placental immunoreactive corticotrophin-releasing factor concentrations in infection-associated term and pre-term delivery 150
Corticotropin-releasing factor-binding protein: Origins and possible functions 149
Prolonged treatment of hirsutism with flutamide alone in patients affected by polycystic ovary syndrome 149
Effects of cyproheptadine clorhydrate, a serotonin receptor antagonist, on endocrine parameters in weight-loss related amenorrhea 148
Melatonin treatment delays reproductive aging of female rat via the opiatergic system. 147
Neuroendocrine changes in luteal function in patients with premenstrual syndrome. 147
Female precocious puberty, obesity and polycystic-like ovaries 146
La Sindrome Premestruale: clinica, fisiopatologia e indicazioni terapeutiche 146
Tibolone, transdermal estradiol or oral estrogen-progestin therapies: Effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels 146
PULSATILE SECRETION OF GONADOTROPINS AND PROLACTIN DURING THE FOLLICULAR AND LUTEAL PHASES OF THE MENSTRUAL-CYCLE - ANALYSIS OF INSTANTANEOUS SECRETION RATE AND SECRETORY CONCOMITANCE 145
Allopregnanolone concentrations and premenstrual syndrome 145
Acetyl-L-Carnitine effect on pituitary and plasma *-endorphin responsiveness to different chronic intermittent stressors. 145
Kisspeptin and LH pulsatile temporal coupling in PCOS patients 145
Life events impact in patients with secondary amenorrhoea. 144
. Opioid control of gonadotrophin secretion in humans. 144
Pulsatile secretion of ACTH and cortisol in premenopausal women: effect of obesity and body fat distribution 142
Estrogen-like effects of wine extracts on nitric oxide synthesis in human endothelial cells 142
The transition from pubertal development to postmenopause discloses a gonadotropin-releasing hormone-independent mechanism regulating follicle-stimulating hormone release 142
Perifollicular Doppler flow and follicular fluid vascular endothelial growth factor concentrations in poor responders 141
Endocrinologia Ginecologica 141
Hypothalamic amenorrhea: Neuroendocrine mechanisms / stress-induced anomalies 141
Long-term low dose dehydroepiandrosterone replacement therapy in aging males with partial androgen deficiency. 141
Estrogens as neuromodulators 141
Assessment of the QoL in Italian menopausal women: Comparison between HRT users and non-users 140
Naltrexone treatment restores menstrual cycles in patients with weight loss-related amenorrhea 140
Contraception as prevention and therapy: sex steroids and the brain 140
Polycystic ovary syndrome: A new ultrasonographic and color Doppler pattern 140
Color Doppler hysterosalpingography in the diagnosis of tubal patency. 139
Spontaneous episodic release of adenohypophyseal hormones in hypothalamic amenorrhea. 139
Stressful life events and affective disorders inhibit pulsatile LH secretion in hypothalamic amenorrhea. 138
Neuromodulatory role of opioidergic system on hypothalamus-pituitary-gonadal axis during puberty 137
Which form of HRT should we choose? 137
Efficacy on menopausal neurovegetative symptoms and some plasma lipids blood levels of an herbal product containing isoflavones and other plant extracts 137
Progestinici e fibromatosi uterina 136
One-year therapy with 10 mg/day DHEA alone or in combination with HRT in postmenopausal women: effects on hormonal milieu 136
Totale 16.766
Categoria #
all - tutte 129.075
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 129.075


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.275 0 0 0 0 0 793 808 475 506 168 309 216
2020/20214.162 366 133 288 330 469 297 392 723 131 572 218 243
2021/20223.487 66 595 353 284 66 116 279 200 355 217 546 410
2022/20233.192 360 282 178 272 396 518 57 285 429 45 154 216
2023/20242.352 93 145 144 152 558 205 248 326 36 74 147 224
2024/20253.699 334 106 80 620 1.540 1.019 0 0 0 0 0 0
Totale 28.470